1. Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestation of COVID-19.

Nat
Med 26, 1017–1032 (2020). https://doi.org/10.1038/s41591-020-0968-3.
2. Ye Q, Wang B, Zhang T, et al. The mechanism and treatment of gastrointestinal symptoms in
patients with COVID-19. Am J Physiol Gastrointest Liver Physiol 319: G245–G252, 2020.
3. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver
damage after 2019-nCoV infection. BioRxiv 2020. https://doi.org/10.1101/2020.02.03.931766.
4. Zhang H, Kang Z, Gong H, et al. Digestive system is a potential route of COVID-19: an analysis
of single-cell coexpression pattern of key proteins in viral entry process. Gut 2020;69:1010-
1018.doi:10.1136/gutjnl-2020-320953.
5. Galanopoulos M, Gkeros F, Doukatas A, et al. COVID-19 pandemic: Pathophysiology and
manifestations from the gastrointestinal tract. World J Gastroenterol 2020; 26(31): 4579-4588.
https://dx.doi.org/10.3748/wjg.v26.i31.4579.
6. Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the
gut-lung axis. Nat Rev Microbiol 15: 55–63, 2017. doi:10.1038/ nrmicro.2016.142.
7. Stenstad H, Ericsson A, Johansson-Lindbom B, et al. Gut-associated lymphoid tissue-primed
CD4 T cells display CCR9- dependent and -independent homing to the small intestine. Blood
107: 3447–3454, 2006. doi:10.1182/blood-2005-07-2860.
8. Fang D, Ma JD, Guan JL, et al. A single-center, descriptive study on the digestive system of
COVID-19 inpatients in wuhan. Chinese J Digest 40: E005–E005, 2020.
9. Jin X, Lian J, Hu J, Gao J, Zheng L, Zhang Y, et al. Epidemiological, clinical and virological
characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal
symptoms. Gut. 2020;69(6):1002-9.
10. Cheung KS, Hung IF, Chan PP, et al. Gastrointestinal manifestations of SARS-CoV-2 infection
and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-
analysis. Gastroenterology. 2020;158:S0016-5085. https://doi.org/10.1053/j. gastro.2020.03.065
PMid:32251668.
11. Pan L, Mu MI, Yang P, et al. Clinical characteristics of COVID-19 patients with digestive
symptoms in Hubei, China: A descriptive, cross-sectional, multicenter study. Am J Gastroenterol.
2020;115(5):766-73. https://doi. org/10.14309/ajg.0000000000000620 PMid:32287140.
12. Guotao L, Xingpeng Z, Zhihui D, Huirui W. SARS-CoV-2 infection presenting with hematochezia.
Med Mal Infect. 2020;50: 293-296.
13. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel
coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323:1061–1069.
14. Henry BM, de Oliveira MHS, Benoit J, Lippi G. Gastrointestinal symptoms associated with
severity of coronavirus disease 2019 (COVID-19): A pooled analysis. Intern Emerg Med. 2020;17:
1-3. doi:10.1007/s11739-020-02329-9
15. Wang W, Xu Y, Gao R, et al. Detection of SARS-CoV-2 in different types of clinical specimens.
JAMA. 2020. DOI:10.1001/jama.2020.3786.
16. Tang A, Tong ZD, Wang HL, et al. Detection of novel coronavirus by RT-PCR in stool specimen
from asymptomatic child, China. Emerg Infect Dis. 2020;26. DOI:10.3201/eid2606.200301.
17. Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2.
Gastroenterology. 2020;158:1831–1833.e3.
18. Jiandong Shi, Jing Sun & Yunzhang Hu. Enteric involvement of SARS-CoV-2: Implications for the
COVID-19 management, transmission, and infection control. Virulence. 2020;11:1, 941-944, DOI:
10.1080/21505594.2020.1794410.
19. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet
Gastroenterol Hepatol. 2020; 5: 428-430. DOI: 10.1016/S2468-1253(20)30057-1.
20. Agarwal A, Chen A, Ravindran N, et al. Gastrointestinal and Liver Manifestations of COVID-19. J
Clin Exp Hepatol. 2020;10:263–265. https://doi.org/10.1016/j.jceh.2020.03.001.
21. Alqahtani SA and Schattenberg JM. Liver injury in COVID-19: The current evidence. United
European Gastroenterol J. 2020 Jun;8(5):509-519. doi: 10.1177/2050640620924157.
22. Brito CA, Barros FM, Lopes EP. Mechanisms and consequences of COVID-19 associated liver
injury: What can we affirm?. World J Hepatol 2020 August 27; 12(8): 1-9. DOI:
10.4254/wjh.v12.i8.0000.
23. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019
novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet 2020; 395: 507–513.
24. Schaefer EAK, Arvind A, Bloom PP, et al. Interrelationship Between Coronavirus Infection and
Liver Disease. Clin. Liver Dis. 2020; 5(15): 175-180.
25. Su TH and Kao JH. The clinical manifestations and management of COVID-19-related liver injury.
J Formos Med Assoc. 2020; 119(6): 1016–1018.
26. Fix OK, Hameed B, Fontana RJ, et al. Clinical best practice advice for hepatology and liver
transplant providers during the COVID-19 Pandemic: AASLD Expert Panel Consensus
Statement. Hepatology. 2020;72(1):287-304. doi: 10.1002/hep.31281.